Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Tango Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 23.88 · gapped above the open, then crossed back over prior close. High/low 24.18 at 9:30 am ET, 23.66 at 10:45 am ET.
247 institutional managers report a position in Tango Therapeutics, Inc. worth $6.7B between them, filed on form 13F for the quarter ending 2026-06-30. 31 of them hold 80% of it, the largest being RTW Investments, LLC at 6.49%.
222 more managers in the register
31 managers hold 80% of the $6.7B institutional base. The other 216 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
TNGX (Tango Therapeutics, Inc.) has 1 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
via RTW Investments, LLC, Paradigm Biocapital Advisors LP, Jupiter Topco LLC +14 more · 6.49% of TNGX, 4.40% of SYRE
via TCG Crossover Management, LLC, Farallon Capital Management LLC, Adage Capital Partners GP, L.L.C. +12 more · 4.24% of TNGX, 4.21% of AVTX
via RTW Investments, LLC, TCG Crossover Management, LLC, Adage Capital Partners GP, L.L.C. +6 more · 6.49% of TNGX, 5.49% of IPSC
via RTW Investments, LLC, Farallon Capital Management LLC, Jupiter Topco LLC +6 more · 6.49% of TNGX, 6.62% of PTGX
via Farallon Capital Management LLC, Paradigm Biocapital Advisors LP, Jupiter Topco LLC +14 more · 5.73% of TNGX, 6.18% of RVMD
via Farallon Capital Management LLC, TCG Crossover Management, LLC, RTW Investments, LLC +6 more · 5.73% of TNGX, 5.17% of IMVT
Managers holding a meaningful stake in TNGX also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.